Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

Elliptic Labs' New Design Win Launches INNER BEAUTY® AI Virtual Proximity Sensortm in Xiaomi Mi 10T Lite Smartphone


Global partners Elliptic Labs, a leading AI software company and Xiaomi, the world's fourth largest smartphone manufacturer, today announced the launch of Xiaomi's new Mi 10T Lite smartphone. This new series is the next in a long line to feature Elliptic Labs' INNER BEAUTY AI Virtual Proximity Sensor as the enabling factor behind its bezel-free design. Elliptic Labs had previously announced the contract win and are making the details available today.

The INNER BEAUTY AI Virtual Proximity Sensor allows smartphone OEMs to replace traditional hardware optical sensors with pure software, performing proximity detection using Elliptic Labs' proprietary algorithms in combination with a phone's existing speaker and microphone. This innovative and market-critical AI Virtual Smart Sensor has empowered OEMs like Xiaomi to introduce bezel-less and bezel-free designs, a significant factor in their rise to becoming a world-leading smartphone manufacturer. Elliptic Labs' AI Virtual Smart Sensor Platform also opens up new experiences for smartphone users like touchless gesture control and presence detection.

"Elliptic Labs is an organization that is constantly focused on innovation and value creation, which is why we are pleased to partner with a like-minded company like Xiaomi," shared Laila Danielsen, CEO of Elliptic Labs. "Our AI Virtual Smart Sensor Platform is creating novel opportunities for smartphone, laptop, IoT and automotive OEMs to really drive digital transformation."

About us

Elliptic Labs is headquartered in Norway with presence in the USA, China, South-Korea, and Japan. Founded in 2006 as a research spin-off from Norway's Oslo University, it is now a global enterprise targeting the smartphone, laptop, IoT, and automotive markets. The Company's patented AI software combines ultrasound and sensor-fusion algorithms to deliver intuitive 3D gesture, proximity and presence sensing experiences. Its scalable AI Virtual Smart Sensor Platform creates software-only sensors that are sustainable, eco-friendly, and already deployed in over 100 million devices. Elliptic Labs is the only software company in the market that has delivered detection capabilities using AI software, ultrasound and sensor-fusion deployed at scale. Elliptic Labs' technology and IP are developed in Norway and solely owned by the Company.

INNER BEAUTY is a registered trademark of Elliptic Labs.

All other trademarks or service markets are the responsibility of their respective organizations.


These press releases may also interest you

at 07:10
D-Wave Quantum Inc., ("D-Wave" or the "Company") a leader in commercial quantum computing systems, software, and services, today announced financial results for its fourth fiscal quarter and year ended December 31, 2023. "Our momentum is...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Zilliant, the leader in pricing lifecycle management, today announced it recently concluded a year of rapid growth, delivering two consecutive quarters of 60%+ growth in year-over-year bookings. The company is positioned for continued record growth...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports. NET v18. This major release includes exciting new features and improvements to the ActiveReports ecosystem....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...



News published on and distributed by: